To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo Fisher Scientific’s Ravi Gupta and Dr. Robert Balog.
There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...
New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research Thermo Fisher Scientific, the ...
The MarketWatch News Department was not involved in the creation of this content. -- Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch" technology and utilizes ...
Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technology Research builds on Emory’s ...
Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...
[Image from Micron Biomedical website] Micron Biomedical announced today that it added $16 million in funding to bring its Series A equity round to more than $33 million. J2 Ventures and the Global ...
Abstract: As a significant technology, microarray technology plays an essential role in the life sciences research field. The processing of the microarray image is one of the critical phases of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback